Thorne HealthTech, Inc. (THRN) Tops Q2 EPS by 9c

Thorne HealthTech, Inc. (NASDAQ: THRN) reported Q2 EPS of $0.15, $0.09 better than the analyst estimate of $0.06. Revenue for the quarter came in at $72.7 million versus the consensus estimate of $68.41 million.

GUIDANCE:

Thorne HealthTech, Inc. sees FY2023 EPS of $0.26-$0.32, versus the consensus of $0.29. Thorne HealthTech, Inc. sees FY2023 revenue of $285-290 million, versus the consensus of $282 million.

For earnings history and earnings-related data on Thorne HealthTech, Inc. (THRN) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c